New Data Detailing the Devastating Nature of Hypophosphatasia (HPP) and Treatment Effect of Asfotase Alfa in Infants, Young Children and Juveniles with HPP Presented at the Pediatric Academic Societies Meeting

New Data Detailing the Devastating Nature of Hypophosphatasia (HPP) and Treatment Effect of Asfotase Alfa in Infants, Young Children and Juveniles with HPP Presented at the Pediatric Academic Societies Meeting

[Business Wire] – Alexion Pharmaceuticals, Inc. today announced that researchers have presented new data from a large, retrospective, natural history study of patients with severe perinatal and infantile hypophosphatasia , an inherited, rare metabolic di more

View todays social media effects on ALXN

View the latest stocks trending across Twitter. Click to view dashboard

See who Alexion is hiring next, click here to view

Share this post